Login / Signup
The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials.
Ibrahim Abubakar
Frank G J Cobelens
Molebogeng X Rangaka
Published in:
American journal of respiratory and critical care medicine (2020)
Keyphrases
</>
mycobacterium tuberculosis
emergency department
pulmonary tuberculosis
combination therapy
electronic health record
smoking cessation